This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Neurocrine Biosciences Inc (NBIX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 31.01M 44.79M 63.75M 50.11M
Receivables 0.00 23.00K 14.09M 1.90M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 4.39M 2.70M 2.16M 1.47M
Total Current Assets 198.20M 148.46M 189.26M 132.48M
Property, Plant & Equipment, Gross 31.25M 30.10M 36.22M 36.47M
Accumulated Depreciation & Depletion 28.75M 28.33M 34.32M 34.89M
Property, Plant & Equipment, Net 2.51M 1.77M 1.90M 1.59M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 42.32M 4.44M 4.82M 4.31M
Total Non-Current Assets 44.83M 6.21M 6.72M 5.89M
Liabilities & Shareholder Equity
Total Assets 243.03M 154.68M 195.98M 138.37M
Accounts Payable 246.00K 101.00K 911.00K 1.11M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 586.00K 3.64M 3.72M 264.00K
Total Current Liabilities 15.66M 11.70M 15.65M 47.11M
Long Term Debt 0.00 0.00 3.10M 0.00
Deferred Income Taxes 1.88M 19.63M 22.71M 1.80M
Other Non-Current Liabilities 16.79M 2.94M 152.00K 29.38M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 18.67M 22.57M 25.96M 31.18M
Total Liabilities 34.33M 34.27M 41.61M 78.29M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 208.70M 120.41M 154.37M 60.08M
Common Par 76.00K 67.00K 66.00K 55.00K
Additional Paid In Capital 1.04B 886.10M 873.98M 784.81M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -826.30M -765.76M -719.67M -724.70M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -277.00K 5.00K -2.00K -87.00K
Total Capitalization 208.70M 120.41M 157.47M 60.08M
Total Equity 208.70M 120.41M 154.37M 60.08M
Total Liabilities & Stock Equity 243.03M 154.68M 195.98M 138.37M
Total Common Shares Outstanding 76.47M 67.35M 66.45M 55.26M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 74.58M 66.99M 65.62M 55.18M
Diluted Weighted Shares Outstanding 74.58M 66.99M 66.95M 56.35M
Number of Employees 94 81 78 71
Number of Part-Time Employees 0 0 0 0

NBIX Neurocrine Biosciences Inc

Chart of NBIX

Analysts Ratings for NBIX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 8 7 7 8
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

NBIX Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs